Crossmark

Advantages and limitations of estrogen replacement therapy on hypogonadal survivors of childhood cancer

Published Online: 2023-08-30

Published Print: 2023-11

Authors

Nakamura, Miwa https://orcid.org/0000-0003-3269-672X
Ohba, Takashi

Sasaki, Rumi

Saito, Fumitaka

Yamaguchi, Munekage

Motohara, Takeshi

Mabe, Hiroyo

Lu, Xi

Katabuchi, Hidetaka

Kondoh, Eiji
License Information

Text and Data Mining valid from 2023-08-30

Version of Record valid from 2023-08-30
More Information

Article History

Received: 11 May 2023

Accepted: 14 August 2023

First Online: 30 August 2023

Declarations

:

: The authors declare no conflicts of interest associated with this manuscript.

Document is current